Cardiologia

Transformação digital dos maiores encontros científicos induzida pela pandemia de COVID-19: lições do Congresso Anual ESC 2020.

25 Ago, 2021 | 12:51h

Digital transformation of major scientific meetings induced by the COVID-19 pandemic: insights from the ESC 2020 annual congress – European Heart Journal Digital Health

 

Comentário no Twitter

One of the COVID-19 induced challenges: How to run a major scientific online meeting as the annual European Society of Cardiology congress with >125.000 registrants?! Read all about it in EHJ – Digital Health https://t.co/Zv2pu6vv5n@escardio @ProfMartinCowie @rafavidalperez pic.twitter.com/utgsebYMoB

— Nico Bruining (@BruiningNico) August 23, 2021

 

---

Estudo randomizado | Inibidores de SGLT2 reduzem o risco de hiperpotassemia em pacientes com diabetes e doença renal crônica.

24 Ago, 2021 | 11:36h

Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial – European Heart Journal (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

SGLT2 inhibition reduces the risk of serious hyperkalemia in people with diabetic kidney disease, which may enable greater use of RAAS inhibitors in CKD and/or heart failure

New CREDENCE data presented this week at #ESCCongress, now in @ESC_Journals:https://t.co/OEqnXTdBDi pic.twitter.com/zsanEFZVCy

— Brendon Neuen (@brendonneuen) August 23, 2021

 

---

Revisão | Uma abordagem pragmática para o desmame de circulação mecânica temporária.

24 Ago, 2021 | 11:30h

A Pragmatic Approach to Weaning Temporary Mechanical Circulatory Support: A State-of-the-Art Review – JACC: Heart Failure

 

Comentário no Twitter

⚠️ A Pragmatic Approach to Weaning Temporary Mechanical Circulatory Support

📌 A State-of-the-Art Review ‼️ in @JACCJournals @secardiologia @AgudosSEC @SACardiologia @JuanFDelgado1 @Dr_Manito @MartaCoboMarcos @MartaFarrero https://t.co/R2vqHwBcfi pic.twitter.com/AraH7AUMu5

— Javier Torres (@JTLLERGO) August 11, 2021

 

---

Diretriz NICE | Síndrome da apneia/hipopneia obstrutiva do sono e síndrome da hipoventilação por obesidade em maiores de 16 anos.

23 Ago, 2021 | 13:07h

Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s – National Institute for Health and Care Excellence

---

M-A | Agonistas receptores de GLP-1 reduzem eventos cardiovasculares adversos maiores, mortalidade por todas as causas, admissão hospitalar por insuficiência cardíaca e piora na função renal em pacientes com diabetes tipo 2.

23 Ago, 2021 | 12:58h

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)

Conteúdo relacionado: Guideline: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

---

M-A | O papel dos inibidores de SGLT2 na insuficiência cardíaca.

23 Ago, 2021 | 12:56h

The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis – Cardiology Research and Practice

Conteúdos relacionados:

ESC Position Paper: Cardiac, renal, and metabolic effects of SGLT2 inhibitors.

Guideline: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

Summary: SGLT2 inhibitors and GLP-1 receptor agonists established and emerging indications.

M-A: SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure.

Meta-analysis: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with Type 2 diabetes

#ESCCongress – [Abstract Only] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

[Abstract Only] Randomized Trial: SGLT2 Inhibitor Improves Outcomes in Patients with Heart Failure Even in the Absence of Diabetes

---

Síndrome taquicárdica pós-Covid-19: um fenótipo da síndrome pós-Covid-19 aguda.

20 Ago, 2021 | 12:25h

Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome – The American Journal of Medicine

 

Comentário no Twitter

Post-COVID19 tachycardia syndrome(s): nice proposal for phenotypeshttps://t.co/XI75HCGYUH pic.twitter.com/yg303QXd1E

— Otavio Ranzani (@otavio_ranzani) August 18, 2021

 

---

Long COVID-19: uma cartilha para profissionais da saúde cardiovascular.

20 Ago, 2021 | 12:23h

Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team – Canadian Journal of Cardiology

---

Dissecção espontânea de artéria coronária: armadilhas do diagnóstico angiográfico e abordagem de casos ambíguos.

20 Ago, 2021 | 12:22h

Spontaneous Coronary Artery Dissection: Pitfalls of Angiographic Diagnosis and an Approach to Ambiguous Cases – JACC: Cardiovascular Interventions

Comentário e resumo: Spontaneous Coronary Artery Dissection Diagnosis – American College of Cardiology

---

Coração, mente e alma: espiritualidade na medicina cardiovascular.

20 Ago, 2021 | 12:20h

Heart, mind, and soul: spirituality in cardiovascular medicine – European Heart Journal

 

Comentário no Twitter

Have you ever thought about the impact of spirituality on cardiovascular outcomes? You’d better meditate….https://t.co/hhf4vRoLxX#cardiotwitter @ESC_Journals @escardio pic.twitter.com/GP8cdZfTP5

— EHJ Editor-in-Chief (@ehj_ed) August 19, 2021

 

---